Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pembrolizumab-Induced Microscopic Colitis.

× No keyword cloud information.

4 in total

1. Keytruda (Pembrolizumab): First PD-1 Inhibitor Approved for Previously Treated Unresectable or Metastatic Melanoma.

Authors: Lisa A Raedler
Journal: Am Health Drug Benefits Date: 2015-03

Review 2. Pembrolizumab: PD-1 inhibition as a therapeutic strategy in cancer.

Authors: J McDermott; A Jimeno
Journal: Drugs Today (Barc) Date: 2015-01 Impact factor: 2.245

Review 3. Immune checkpoint inhibitors in clinical practice: update on management of immune-related toxicities.

Authors: Jeryl Villadolid; Asim Amin
Journal: Transl Lung Cancer Res Date: 2015-10

4. Anti-PD1-induced collagenous colitis in a melanoma patient.

Authors: Barouyr Baroudjian; Nelson Lourenco; Cécile Pagès; Ichrak Chami; Marianne Maillet; Philippe Bertheau; Martine Bagot; Jean-Marc Gornet; Céleste Lebbé; Matthieu Allez
Journal: Melanoma Res Date: 2016-06 Impact factor: 3.599

4 in total

2 in total

1. Secukinumab-Induced Lymphocytic Colitis.

Authors: Siva Santosh Kumar Gandu; Mohammad Hassaan Khan; Anush Vasikaran; Sudha Pandit
Journal: J Investig Med High Impact Case Rep Date: 2022 Jan-Dec

Review 2. First line Immunotherapy for Non-Small Cell Lung Cancer.

Authors: Nicola J Nasser; Miguel Gorenberg; Abed Agbarya
Journal: Pharmaceuticals (Basel) Date: 2020-11-08

2 in total